Trial Profile
Relative Efficacy of Repeat Course of Intravenous methyLprednisolone and Intramuscular ACTH in the Treatment of Acute Relapse of Multiple Sclerosis After Sub Response to Initial Course of Intravenous Methylprednisolone (RECLAIM): a Single Center Pilot Study
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary) ; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms RECLAIM
- 06 Sep 2011 Planned end date changed from 1 Sep 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 06 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 31 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.